IPO SnapShot

KIDS MEDICAL SYSTEMS LTD.

IPODATE
Dec 11, 2017 TO Dec 14, 2017
LISTINGDATE
12/22/2017 12:00:00 AM
APPLY NOW
FACEVALUE
₹ 10

per share

ISSUESIZE
₹ 6 Cr
PRICEBAND
₹ 30

per share

MARKETLOT
4000

shares

OBJECTIVE

The objects of the Issue are:1. To set up healthcare Clinics and purchase of interiors, furniture and allied infrastructure 2. General Corporate Purpose 3. Meeting Public Issue Expenses.

DON'T HAVE A DEMAT ACCOUNT

OPENDEMAT ACCOUNTAND START YOURINVESTMENTJOURNEY WITH US

OPEN AN ACCOUNT (You will receive a call & SMS from our end)
BUSINESS DESCRIPTION

Company Background and Overview Our Company is engaged in providing solution in healthcare sector as pediatric clinic chain provider. We offer exclusive services which can benefit the child for theirhealthcare needs.Kids Clinic (TKC) is a venture of "Kids Medical Systems Private Ltd"started in June, 2013 and our company has launched our first ?? pediatric clinic chain.We partner with doctors at...

ADDRESS

Address: F-806 Titanium City Center
Nr. Sachin Towers
100 Feet Ring Road
Anand Nagar Road
Satellite
City: Ahmedabad,
State: Gujarat
Pincode: 380015
Phone: 079-48989930
Email: pallavi.dam@thekidsclinic.in
Website: www.thekidsclinic.in

LISTED AT

BSE

LEAD MANAGER

Gretex Corporate Services Pvt Ltd.

PROMOTERS

Anirvan Amitava Dam
Pallavi Anirvan Dam

PROMOTER'S HOLDING

Total Share Capital

3929254

Offered to Public

2000000

Promoter's Holding (Pre-Issue)

77.18

Promoter's Holding (Post-Issue)

55.41
REGISTRAR

Purva Shareregistry (India) Pvt Ltd
33 Printing House
28 D Police Court Lane
Behind Old Handloom House
Fort
Mumbai

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.